找到338记录 | 不满意,请使用左下搜索矩阵
排序: 相关性 发表日期 影响因子

The field of gut microbiota is of growing interest, especially in the recent discoveries of its i...

期刊:J Oncol Pharm Pract  影响因子:0.0  发表日期: 20170101  PMID: 28625074 


From the application of Coley's toxin in the early 1900s to the present clinical trials using imm...

期刊:Tumour Biol  影响因子:0.0  发表日期: 20170601  PMID: 28639883 


Over the past several years remarkable therapeutic responses have been obtained with immunomodula...

期刊:Hum Antibodies  影响因子:0.0  发表日期: 20170101  PMID: 28085017 


Immunotherapeutics have revolutionized the management of solid malignancies over the last few yea...

期刊:Oncotarget  影响因子:5.168  发表日期: 20180427  PMID: 29854316 


Inhibitory antibodies targeting programmed death protein 1 (PD-1) and programmed death ligand 1 (...

关键词: CheckMate    IMpower    KEYNOTE    NSCLC    checkpoint inhibitors    clinical trials   
期刊:Front Oncol  影响因子:4.137  发表日期: 20190101  PMID: 30984621 


Melanoma is a highly aggressive tumor with a strong dependence on intracellular signaling pathway...

期刊:Cancers (Basel)  影响因子:6.162  发表日期: 20190403  PMID: 30987166 


期刊:Immunotherapy  影响因子:3.028  发表日期: 20190201  PMID: 30730272 


AIM: In this meta-analysis, we evaluated several predictors of benefit to single-agent immune che...

期刊:Immunotherapy  影响因子:3.028  发表日期: 20190201  PMID: 30730276 


    相关搜索: